Advertisement

Topics

Adalimumab biosimilars Amgevita and Imraldi launched in Europe

05:34 EDT 2 Nov 2018 | Generics and Biosimilars Initiative

In October 2018, two adalimumab biosimilars have been launched in the European Union (EU). Amgen announced the European launch of its adalimumab biosimilar, Amgevita and Biogen announced the launch of its adalimumab biosimilar Imraldi.

Original Article: Adalimumab biosimilars Amgevita and Imraldi launched in Europe

NEXT ARTICLE

More From BioPortfolio on "Adalimumab biosimilars Amgevita and Imraldi launched in Europe"

Advertisement
Quick Search
Advertisement
Advertisement